Novation Applauds FDA's Unique Device Identification Rule
IRVING, Texas, July 5, 2012 /PRNewswire/ -- The Food and Drug Administration's release of a proposed rule implementing a Unique Device Identification (UDI) system for medical devices represents a significant milestone for patient safety.
Novation, the health care industry's leading supply contracting company for the members and affiliates of VHA Inc, UHC, Children's Hospital Association and Provista, has been an active advocate of UDI implementation for several years.
"A robust UDI system will significantly enhance product identification, improve the device recall process, and ensure the integrity of the product throughout the transportation process, and most importantly, advance and improve patient safety," says Dan Sweeney, senior vice president of information and data services at Novation. "A UDI system also has the potential to generate significant savings for the health care industry through improved efficiencies and automated processes. Given the dramatic changes in finances and urgent patient safety needs, health care organizations and patients will benefit most from a swift implementation of a UDI system."
About Novation, Winner of the Ethics Inside® Certification
Founded in 1998, Novation is the leading health care supply chain expertise and contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase more than $40 billion in 2011. Novation recently earned the coveted Ethics Inside® Certification from Ethisphere Institute, a